$LDOS

Leidos wins $56 million Navy behavioral health research contract

Leidos (LDOS) won a $56M contract from the Naval Health Research Center for behavioral health research over 66 months. The company will analyze data and develop strategies to enhance military personnel readiness. Leidos reported $17.2B in annual revenue for FY2026.

Original reporting
Published Oct 15, 2026, 1:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 1:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$LDOS
Bullish
high confidence
Mentioned
$LDOS
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LDOSBullishMed
01

Why it matters

The $56 M award expands Leidos' behavioral health research capabilities for the Navy, reinforcing its defense portfolio.

02

Market read

A new federal contract of this size is a positive catalyst for Leidos and may lift defense sector sentiment.

03

What to watch

Potential execution risk and future funding uncertainties for the Navy program.

Relevance 7/10Novelty 7/10Timing: today

Background

Leidos (LDOS) is a major U.S. defense and IT services firm; federal contracts are a core revenue source.

Company-level read

Ticker impact

$LDOSBullishHigh confidence
Context

Leidos was awarded a $56 million, 66‑month Navy behavioral health research contract, disclosed for the first time.

Expected impact

likely modest upside as the market prices in the incremental revenue.

Evidence & confidence

A fresh multi‑year federal contract is material for a defense contractor and typically supports the stock.

Market effects

May boost sentiment for defense and government‑contractors sector.

Limited to U.S. defense equities.

Low; primarily a U.S. defense contractor story.

Counterpoint

If the contract is seen as incremental rather than transformational, the stock may already be priced in.

Key entities

  • Leidos

    U.S. defense contractor receiving the contract.

  • Naval Health Research Center

    Awarding agency for the behavioral health research contract.

Related articles

$LDOSMed

Leidos To Support Naval Health Research Center With Studies To Improve Health and Readiness of U.S. Service Members

Leidos (LDOS) received a $56M contract from the Naval Health Research Center to provide behavioral health research and data analysis to improve U.S. military personnel's readiness. The 66-month contract focuses on psychological health and operational readiness, leveraging Leidos' 50+ years of experience. LDOS reported $17.2B in annual revenue for FY2026.

$LDOSMed

U.S. Navy Deploys Leidos' Autonomous Seahawk Vessel with USS The

Leidos Holdings Inc. (LDOS) deployed its autonomous Seahawk vessel with the USS Theodore Roosevelt carrier strike group, marking a first for naval operations. The company's stock is trading at $120.59, 30.2% below its GF Value™ of $172.78, indicating undervaluation. Leidos has a GF Score™ of 85, reflecting strong profitability and growth. Insiders have sold $3.2 million in shares over the past year.

$LDOSMed

DHA, Leidos finalize bridge contract for health record transition

The Defense Health Agency finalized a $317.9M bridge contract with Leidos for the military's electronic health record transition, extending through January 2028. The contract covers system reintegration and software licensing, aiming to facilitate transitions to other providers. DHA plans direct contracts with Oracle Health, Philips North America, American Well Corp, Henry Schein, and Solventum Health Information Systems.

$LDOSMed

MOD Extends Leidos LCST Contract Through June 2029

Leidos Holdings (LDOS) extended its Logistics Commodities and Services Transformation (LCST) contract with the UK Ministry of Defense through June 2029. The contract, held since 2015, supports logistics for the UK armed forces, managing 70,000+ NATO Stock numbers and delivering £400M in benefits. LDOS shares closed at $119.70 on Tuesday, down 1.56%.